Summary
A single oral dose (40 mg) of tenoxicam (Ro12-0068) was administered to six normal male volunteers pre- and post-prandially and to a further six volunteers with and without antacid to determine the effect of food and and of antacid on absorption.
The rate of absorption was slower with post-prandial than with pre-prandial administration, resulting in a significantly later time for peak plasma drug levels (4.1 h compared to 1.3 h). No effect was evident on the extent of absorption or other pharmacokinetic parameters.
Similarly, the rate of absorption was significantly slower after concurrent antacid than without antacid (t1/2 0.47 h compared to 0.18 h) resulting in a later peak time (4.7 h compared to 2.3 h) and significantly lower peak level (4.2μ.ml−1 compared to 5.μJ.g.ml−1) of parent drug in plasma. Again, no effect was evident on the extent of absorption or other pharmacokinetic parameters.
It is concluded that food and antacids both tend to reduce the rate of absorption of tenoxicam, but that the extent of absorption is essentially unchanged. The influence on the overall kinetic profile is relatively minor, and thus unlikely to affect the therapeutic response.
Similar content being viewed by others
References
Strub K.M., Aeppli L. and Daum A. (1984): Antiinflammatory and analgesic effects of tenoxicam (Tilcotil) in rats. Abstract read at III International Congress of Inflammation, Paris.
Heintz R.C., Guentert T.W., Enrico J.F., Dubach V.C., Brandt R. and Jeunet F.S. (1984): Pharmacokinetics of tenoxicam in healthy human volunteers. Eur. J. Rheumatol. Inflam.
Pickup M.E., Lowe J.R. and Galloway D.B. (1981): Determination of Ro12-0068, a new anti-inflammatory and analgesic compound, in plasma by means of highperformance liquid chromatography. J. Chromatog.,225, 493–497.
Dixon J.S., Lowe J.R. and Galloway D.B. (1984): Rapid method for the determination of either piroxicam or tenoxicam in plasma using high-performance liquid chromatography. J. Chromatog.,310, 455–459.
Francis R.J. (1984): ELSMOS — An extended leastsquares modelling system in FORTRAN IV for mini- or micro-computer implementation. Compo Prog. Biomed.,18, 43–49.
Wiseman E.H. and Lombardino J.G. (1981): Oxicams a novel family of non-steroidal anti-inflammatory drugs. Eur. J. Rheumatol.,4, 280–297.
Brogden R.N., Heel R.C., Speight T.M. and Avery G.S. (1981): Piroxicam: a review of its pharmacological properties and therapeutic efficacy. Drugs,22, 165–187.
Ishizaki T., Nomwa T. and Abe T. (1979): Pharmacokinetics of piroxicam, a new non-steroidal anti-inflammatory agent, under fasting and post-prandial states in man. J. Pharmacokinet. Biopharm.,7, 369–381.
Tilstone W.J., Lawson D.H., Omana F. and Cunningham F. (1981): The steady-state pharmacokinetics of piroxicam: effect of food and iron. Eur. J. Rheumatol.,4, 309–313.
Hobbs D.C. and Twomey T.M. (1979): Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies. J. Clin. Pharmacol.,19, 270–281.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Francis, R.J., Dixon, J.S., Lowe, J.R. et al. The effects of food and of antacid on the single oral dose pharmacokinetics of tenoxicam. European Journal of Drug Metabolism and Pharmacokinetics 10, 309–314 (1985). https://doi.org/10.1007/BF03189758
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189758